男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

Indian company launches injectable drug for severe COVID-19 patients

Xinhua | Updated: 2020-06-22 16:26
Share
Share - WeChat

MUMBAI - Indian pharmaceutical company Cipla has launched remdesivir lyophilized powder for 100mg injection to treat severe COVID-19 patients in the domestic market, a company statement said, late Sunday.

Remdesivir is a broad-spectrum antiviral medication developed by the US based biopharmaceutical company Gilead Sciences, who had extended a voluntary non-exclusive license to a handful Indian and Pakistani companies including Cipla to manufacture and market the drug.

"We have been deeply invested in exploring all possible avenues to save millions of lives impacted by COVID-19 pandemic, and this launch is a significant milestone in that direction. We will continue to collaborate with all stakeholders in the healthcare ecosystem towards providing access to such promising treatments in furtherance with our belief that no patient should be denied access to life-saving treatments," said Umang Vohra, Managing Director and Global CEO, Cipla Limited, without disclosing the pricing of the injectable drug.

Last week, another Indian company Glenmark Pharmaceuticals had launched anti-viral drug Favipiravir for the treatment of mild to moderate COVID-19 patients in the domestic market at $1.35 per tablet.

Cipla will be commercializing remdesivir through its own facilities and partnered sites and will supply the drug through government and open market channels, to ensure equitable distribution.

As on Monday morning, India, ranked fourth among all countries for confirmed COVID-19 cases, has 174,387 active cases with 13,699 deaths reported so far.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 宣城市| 桃园县| 磐安县| 彭山县| 松潘县| 扶风县| 张家界市| 怀安县| 泾阳县| 和硕县| 南皮县| 上高县| 大竹县| 通化县| 黑龙江省| 宿松县| 漳浦县| 即墨市| 云梦县| 鲁山县| 郁南县| 米易县| 德保县| 平南县| 远安县| 循化| 偃师市| 诸暨市| 新野县| 濉溪县| 丰宁| 中宁县| 绵竹市| 凤山县| 永年县| 蒲江县| 曲松县| 中江县| 玉屏| 綦江县| 宝山区|